Dr. Laramore on Genetic Testing in Hematologic Cancers

Video

Andrew Laramore, MD, Anatomic and Clinical Pathology, Diagnostic Pathology Services, discusses some of the known genes that are tested for in hematologic malignancies.

Andrew Laramore, MD, Anatomic and Clinical Pathology, Diagnostic Pathology Services, discusses some of the known genes that are tested for in hematologic malignancies.

Many genetic panels can test anywhere from 3 to 600 hotspots. However, pathologists are inundated with data, and the significance of the information doesn’t necessarily translate upfront. It's similar to “putting the cart in front of the horse” in some circumstances, says Laramore.

In chronic myeloid leukemia (CML), pathologists can do BCR-ABL1 fluorescence in situ hybridization testing. A positive result is most likely chronic myeloid leukemia. However, in many instances, mostly in myeloid dysplasia workups, pathologists will see mutations that are not clearly related to disease. They may simply be part of the normal aging process. The role of next-generation sequencing in the diagnosis of myeloid disorders, particularly neurologic deficit scores, will become very important in that regard.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD